Q2 2017 EPS Estimates for Sharps Compliance Corp. Decreased by Analyst (SMED)
Sharps Compliance Corp. (NASDAQ:SMED) – Stock analysts at First Analysis dropped their Q2 2017 EPS estimates for shares of Sharps Compliance Corp. in a note issued to investors on Thursday. First Analysis analyst J. Munda now anticipates that the firm will post earnings per share of $0.04 for the quarter, down from their prior estimate of $0.08. First Analysis currently has a “Equal Weight” rating and a $6.00 target price on the stock. First Analysis also issued estimates for Sharps Compliance Corp.’s Q4 2017 earnings at $0.06 EPS and Q1 2018 earnings at ($0.02) EPS.
Sharps Compliance Corp. (NASDAQ:SMED) last announced its earnings results on Wednesday, October 26th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by $0.03. The firm earned $9.50 million during the quarter, compared to analysts’ expectations of $9.52 million. Sharps Compliance Corp. had a negative return on equity of 1.48% and a negative net margin of 3.35%. The company’s revenue for the quarter was up 21.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.01 earnings per share.
Separately, Zacks Investment Research cut Sharps Compliance Corp. from a “hold” rating to a “strong sell” rating in a report on Wednesday, August 17th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $7.50.
Sharps Compliance Corp. (NASDAQ:SMED) opened at 4.22 on Monday. The stock’s market capitalization is $67.12 million. Sharps Compliance Corp. has a 12 month low of $3.32 and a 12 month high of $9.77. The firm has a 50-day moving average price of $4.10 and a 200 day moving average price of $4.51.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in SMED. Northern Trust Corp raised its position in Sharps Compliance Corp. by 1.0% in the third quarter. Northern Trust Corp now owns 24,094 shares of the company’s stock valued at $106,000 after buying an additional 239 shares during the last quarter. Oxford Asset Management raised its position in Sharps Compliance Corp. by 210.3% in the second quarter. Oxford Asset Management now owns 33,853 shares of the company’s stock valued at $149,000 after buying an additional 22,943 shares during the last quarter. Mesirow Financial Investment Management Equity Management bought a new position in Sharps Compliance Corp. during the third quarter valued at approximately $278,000. Ingalls & Snyder LLC bought a new position in Sharps Compliance Corp. during the second quarter valued at approximately $318,000. Finally, Anderson Hoagland & Co. raised its position in Sharps Compliance Corp. by 171.1% in the second quarter. Anderson Hoagland & Co. now owns 84,610 shares of the company’s stock valued at $371,000 after buying an additional 53,404 shares during the last quarter. 24.86% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this news story can be read at https://www.thecerbatgem.com/2016/11/23/q2-2017-eps-estimates-for-sharps-compliance-corp-decreased-by-analyst-smed.html.
About Sharps Compliance Corp.
Sharps Compliance Corp. is a service provider of waste management services, including medical, pharmaceutical and hazardous. The Company’s solutions facilitate the proper collection, containment, transportation and treatment of numerous types of healthcare-related materials, including hypodermic needles, lancets and other devices or objects used to puncture or lacerate the skin, or sharps, and unused consumer dispensed medications and over-the-counter drugs.
Receive News & Stock Ratings for Sharps Compliance Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance Corp. and related stocks with our FREE daily email newsletter.